At this year's @Jefferies Global Healthcare Conference, we are looking forward to our Founder & CEO @DavidBerry26 discussing how @ValoHealth is driving digital transformation of drug discovery for patients. #JefferiesHealthcare https://t.co/YjefOac5pk
Valo's CEO & Founder @DavidBerry26 is presenting at the @jpmorgan Healthcare Conference on Tuesday, January 10th at 2:30 PM PT. Come find the Valo team to learn more about how we are transforming drug discovery https://t.co/BHbziX8sDm
Evaluating the efficacy and safety of a novel prophylactic nasal spray in the prevention of SARS-CoV-2 infection: A multi-centre, double blind, placebo-controlled, randomised trial. - ScienceDirect https://t.co/7MGjzRYhqu
We are thrilled to announce the launch of Logica, a customized turnkey drug discovery solution from target to preclinical development. @ValoHealth and @CRiverLabs are transforming #drugdiscovery with Logica, learn more here: https://t.co/rIyq7D0mE3
Congrats to all our colleagues at Flagship-founded @ValoHealth on partnering with @CRiverLabs --aiming to speed up drug discovery with AI. @DavidBerry26
An exciting day! @ValoHealth and @CRiverLabs
join forces to provide clients with AI-enabled drug discovery solutions that aim to transform the entire preclinical drug discovery process. @TheAlexKnapp#artificialintelligence https://t.co/5fC6TRPurn
Great news at Valo this morning with the announcement of Dave Morris, MD as our Chief Medical Officer. Welcome to the team Dave! https://t.co/yYqBx8cUOf
It's that time of year again! Valo's CEO and founder David Berry will be presenting at the 40th annual J.P. Morgan Healthcare Conference on Wednesday, January 12th at 8:30 AM - replay will be available at https://t.co/8S1TZ9QfAp
https://t.co/X49WahSJ0X
Valo is honored to have been chosen by Fierce Biotech as one of this year's Fierce 15 for our approach to transforming drug discovery & development https://t.co/bOMOBWhLdH
Valo is thrilled to be included in @KatieMPalmer@statnews list of 5 companies to watch that are harnessing AI for drug discovery https://t.co/8cFs1HUuAy
@DavidBerry26
Valo is thrilled to welcome Judy Lewent to our Board of Directors!
Judy brings 30+ years of experience in pharmaceuticals and technology to the Valo team and we’re excited to have her leadership as we reimagine the future of intelligent health.
https://t.co/nS4NWNBAsP
We’re excited to announce that Valo Health has entered into a definitive merger agreement with Khosla Ventures Acquisition Co. We look forward to this incredible partnership and our continued growth https://t.co/UOH8YSeFEb
Here at Valo, we're revolutionizing drug discovery so that every disease has a treatment.
Learn more about how our approach to target discovery and drug development is ushering in a new era of intelligent health: https://t.co/anfoRV9hZS
Valo’s @DavidBerry26 is presenting at the @UBS Global Healthcare Virtual Conference at 4pm ET.
You can watch a live webcast of the presentation after the event on the Valo website here: https://t.co/EZKiRof5Gj
Valo is a technology company transforming the drug discovery and development process using human and machine intelligence to accelerate the creation of life-changing treatments.
Learn how we are making this possible: https://t.co/WMCN6CytgF #IntelligentHealth
Today, Valo announced the final closing of its #SeriesB at $300 million, including a $110 million investment from Koch Disruptive Technologies.
Read more on our Series B close here: https://t.co/Mt90uVpjOn